US6927212B2ExpiredUtilityA1

Design and synthesis of renal dipeptidase inhibitors

64
Assignee: UNIV JOHNS HOPKINSPriority: Jul 27, 2002Filed: Jul 28, 2003Granted: Aug 9, 2005
Est. expiryJul 27, 2022(expired)· nominal 20-yr term from priority
C07F 9/303C07B 2200/05C07B 59/004A61K 51/0489
64
PatentIndex Score
4
Cited by
4
References
8
Claims

Abstract

Aminophosphinic acid derivatives were synthesized as potential inhibitors of renal dipeptidase, an enzyme overexpressed in benign and malignant colon tumors. Several compounds showed potent enzyme-inhibitory activity. These compounds can be used therapeutically and diagnostically for treatment and detection of tumors.

Claims

exact text as granted — not AI-modified
1. A compound of formula I: 
                 
 
       wherein
 X is selected from the group consisting of F, Cl, Br,  125 I, I, CF 3 , NR′, and radioisotopes thereof;  
 Y is selected from the group consisting of H, CH 3 , OCH 3 , CF 3 , F, Cl,  125 I, NR′, and radioisotopes thereof;  
 NR′ is selected from NH 2 , N(C1 to C6 alkyl) 2 , and NH (C1 to C6 alkyl);  
 Z is selected from the group consisting of O, S, and radioisotopes thereof.  
 
     
     
       2. The compound of  claim 1  which is the E isoform. 
     
     
       3. The compound of  claim 1  which is the Z isoform. 
     
     
       4. The compound of  claim 1  which is radiolabeled. 
     
     
       5. The compound of  claim 1  wherein at least one atom of X or Y is radiolabeled. 
     
     
       6. The compound of  claim 1  wherein at least one of X or Y is an  125 I atom. 
     
     
       7. A sterile, apyrogenic formulation for intravenous administration to a human subject comprising:
 the compound of  claim 1 ; and  
 water.  
 
     
     
       8. The method of inhibiting colon tumor growth, comprising:
 administering to a subject carrying a colon tumor an effective amount of a compound of  claim 1 , whereby growth of the colon tumor is inhibited.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.